Literature DB >> 11390012

Longitudinal study of resting energy expenditure, body cell mass and the inflammatory response in male patients with non-small cell lung cancer.

H R Scott1, D C McMillan, W S Watson, R Milroy, C S McArdle.   

Abstract

The aim of this study was to examine the inter-relationship between the inflammatory response and resting energy expenditure in patients with non-small cell lung cancer (NSCLC) before and after the onset of weight loss. Healthy subjects (n=7) and patients with NSCLC without weight loss (n=12) were studied. Resting energy expenditure adjusted for metabolically active tissue, as measured by total body potassium, was approximately 15% higher in the NSCLC group (P<0.01). Moreover, the resting energy expenditure, correlated with the magnitude of the inflammatory response (r=0.753, P<0.01). Six cancer patients subsequently lost weight and the relationship between resting energy expenditure and the inflammatory response was maintained. These results highlight the impact of the inflammatory response on the increase in the resting energy expenditure which precedes the onset of weight loss in patients with NSCLC.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11390012     DOI: 10.1016/s0169-5002(00)00244-0

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  10 in total

Review 1.  Key determinants of energy expenditure in cancer and implications for clinical practice.

Authors:  S A Purcell; S A Elliott; V E Baracos; Q S C Chu; C M Prado
Journal:  Eur J Clin Nutr       Date:  2016-06-08       Impact factor: 4.016

2.  Relationship between weakness and phase angle in advanced cancer patients with fatigue.

Authors:  A Navigante; P Cresta Morgado; O Casbarien; N López Delgado; R Giglio; M Perman
Journal:  Support Care Cancer       Date:  2013-01-16       Impact factor: 3.603

3.  C-reactive protein, interleukin 6 and lung cancer risk: a meta-analysis.

Authors:  Bo Zhou; Jing Liu; Ze-Mu Wang; Tao Xi
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

Review 4.  The assessment and impact of sarcopenia in lung cancer: a systematic literature review.

Authors:  Jemima Collins; Simon Noble; John Chester; Bernadette Coles; Anthony Byrne
Journal:  BMJ Open       Date:  2014-01-02       Impact factor: 2.692

Review 5.  Cancer-Associated Muscle Wasting-Candidate Mechanisms and Molecular Pathways.

Authors:  Victoria S Armstrong; Liam W Fitzgerald; Oliver F Bathe
Journal:  Int J Mol Sci       Date:  2020-12-04       Impact factor: 5.923

Review 6.  Exercise in People With Cancer: A Spotlight on Energy Regulation and Cachexia.

Authors:  Jessica Allan; Linda A Buss; Nick Draper; Margaret J Currie
Journal:  Front Physiol       Date:  2022-02-25       Impact factor: 4.566

Review 7.  Leucine Supplementation in Cancer Cachexia: Mechanisms and a Review of the Pre-Clinical Literature.

Authors:  Anna G Beaudry; Michelle L Law
Journal:  Nutrients       Date:  2022-07-09       Impact factor: 6.706

Review 8.  A systematic review of the association between circulating concentrations of C reactive protein and cancer.

Authors:  Katriina Heikkilä; Shah Ebrahim; Debbie A Lawlor
Journal:  J Epidemiol Community Health       Date:  2007-09       Impact factor: 3.710

9.  The impact of baseline serum C-reactive protein and C-reactive protein kinetics on the prognosis of metastatic nasopharyngeal carcinoma patients treated with palliative chemotherapy.

Authors:  Wei-Xiong Xia; Yan-Fang Ye; Xing Lu; Lin Wang; Liang-Ru Ke; Hai-Bo Zhang; Mark D Roycik; Jing Yang; Jun-Li Shi; Ka-Jia Cao; Xiang Guo; Yan-Qun Xiang
Journal:  PLoS One       Date:  2013-10-10       Impact factor: 3.240

10.  The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer.

Authors:  H R Scott; D C McMillan; L M Forrest; D J F Brown; C S McArdle; R Milroy
Journal:  Br J Cancer       Date:  2002-07-29       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.